Ubs Global Asset Management Americas »

Edgewise Therapeutics shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $591k 32k 18.24
2023-12-31 $258k 24k 10.94

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Nvidia Corp Equity Us Cm (NVDA)
Amazon Equity Us Cm (AMZN)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Meta Platforms Equity Us Cm (META)
Ishares Core Msci Eafe Equity (IEFA)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Eli Lilly &#38 Equity Us Cm (LLY)
Broadcom Equity Us Cm (AVGO)
Tesla Equity Us Cm (TSLA)
Unitedhealth Group Equity Us Cm (UNH)
Advanced Micro Devices Equity Us Cm (AMD)
Visa Inc Class A Shares Equity Us Cm (V)
Jpmorgan Chase &#38 Company Equity Us Cm (JPM)

View all positions for Ubs Global Asset Management Americas

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
FMR
Baker Bros. Advisors
BlackRock
Vanguard Group
Viking Global Investors
Frazier Life Sciences Management
Cormorant Asset Management
Deerfield Management Company
Citadel Advisors
Paradigm Biocapital Advisors
Perceptive Advisors
VR Adviser
Henderson Group

View all funds holding Edgewise Therapeutics